Hiberix - Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)
Proper Name: Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)
Tradename: Hiberix
Manufacturer: GlaxoSmithKline Biologicals, S.A.,
Indication:
For active immunization for the prevention of invasive disease caused by Haemophilus influenzae type b when administered as a booster dose in children 15 months through 4 years of age (prior to fifth birthday).
abrir aquí para acceder al documento FDA completo:
Hiberix - Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)
No hay comentarios:
Publicar un comentario